LeMaitre Vascular, Inc. (LMAT) Earnings History
Elite Compounder22 years of earnings data (2004–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality
Loading earnings history...
LeMaitre Vascular, Inc. (LMAT) Earnings Overview
As of October 3, 2026, LeMaitre Vascular, Inc. (LMAT) reported trailing twelve-month net income of $66M, reflecting +30.6% year-over-year growth. The company earned $2.68 per diluted share over the past four quarters, with a net profit margin of 23.1%.
Looking at the long-term picture, LMAT's 5-year EPS compound annual growth rate (CAGR) stands at +19.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $58M in fiscal 2025, representing a new all-time high.
LeMaitre Vascular, Inc. maintains industry-leading profitability with a gross margin of 71.5%, operating margin of 27.2%, and net margin of 23.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ATRC ($11M net income, -2.1% margin), NVCR (-$149M net income, -20.8% margin), ANGO (-$37M net income, -11.5% margin), LMAT has outperformed on profitability metrics. Compare LMAT vs ATRC →
LMAT Earnings vs Peers
Earnings metrics vs comparable public companies
LMAT Historical Earnings Data (2004–2025)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $58M | +31.1% | $68M | $2.52 | 23.1% | 27.2% |
| 2024 | $44M | +46.3% | $52M | $1.93 | 20.0% | 23.8% |
| 2023 | $30M | +45.9% | $37M | $1.34 | 15.6% | 19.0% |
| 2022 | $21M | -23.3% | $27M | $0.93 | 12.8% | 16.6% |
| 2021 | $27M | +26.8% | $36M | $1.25 | 17.4% | 23.6% |
| 2020 | $21M | +18.3% | $29M | $1.04 | 16.4% | 22.3% |
| 2019 | $18M | -21.8% | $21M | $0.88 | 15.3% | 18.1% |
| 2018 | $23M | +33.6% | $28M | $1.13 | 21.7% | 26.7% |
| 2017 | $17M | +62.2% | $21M | $0.86 | 17.0% | 20.9% |
| 2016 | $11M | +36.5% | $16M | $0.55 | 11.9% | 18.3% |
| 2015 | $8M | +98.2% | $12M | $0.42 | 9.9% | 14.7% |
| 2014 | $4M | +22.3% | $6M | $0.23 | 5.5% | 8.9% |
| 2013 | $3M | +24.5% | $5M | $0.20 | 5.0% | 7.0% |
| 2012 | $3M | +20.0% | $4M | $0.16 | 4.5% | 7.5% |
| 2011 | $2M | -64.4% | $4M | $0.13 | 3.7% | 6.4% |
| 2010 | $6M | +276.3% | $4M | $0.37 | 10.7% | 7.2% |
| 2009 | $2M | +148.2% | $2M | $0.10 | 3.1% | 3.8% |
| 2008 | -$3M | -13.0% | -$3M | $-0.21 | -6.8% | -6.0% |
| 2007 | -$3M | -150.3% | -$4M | $-0.19 | -7.1% | -10.3% |
| 2006 | -$1M | -2230.9% | $-679,000 | $-0.12 | -3.4% | -2.0% |
| 2005 | $55,000 | -94.1% | $422,000 | $0.01 | 0.2% | 1.4% |
| 2004 | $927,000 | - | $1M | $0.10 | 3.5% | 4.4% |
Download Data
Export LMAT earnings history in CSV or JSON format
Free sign-in required to download data
LMAT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
22+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LMAT — Frequently Asked Questions
Quick answers to the most common questions about buying LMAT stock.
What is LMAT earnings per share (EPS)?
LMAT trailing twelve-month (TTM) diluted EPS is $2.68, reflecting +30.6% year-over-year growth. The 5-year EPS CAGR is +19.4%. Complete EPS history from 2004 to 2025 is available in the table on this page.
What is LeMaitre Vascular, Inc.'s net income?
LeMaitre Vascular, Inc. (LMAT) trailing twelve-month net income is $66M as of 2025. Earnings grew +30.6% year-over-year. LeMaitre Vascular, Inc. has been profitable for 17 consecutive years.
Is LMAT profitable?
Yes, LMAT is profitable with a TTM net income of $66M and a net profit margin of +23.1%. LeMaitre Vascular, Inc. has generated profits for 17 consecutive years.
What is LMAT's earnings growth rate?
LMAT compound annual EPS growth rates (CAGR): 1-Year: +30.6%, 3-Year: +39.4%, 5-Year: +19.4%, 10-Year: +19.6%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2004 to 2025.
What are LMAT's profit margins?
LeMaitre Vascular, Inc. net profit margin is +23.1%, operating margin is +27.2%, and gross margin is +71.5%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +15.8%.
Is LMAT growing earnings?
Yes, LMAT earnings are accelerating — EPS growth of +30.6% exceeds the 5-year CAGR of +19.4%. TTM net income reached $66M. Earnings momentum is strengthening.
What was LMAT's best earnings year?
LeMaitre Vascular, Inc.'s highest annual net income on record is $58M, achieved in fiscal year 2025. Earnings history on this page spans 2004 to 2025 and includes all annual and quarterly figures.
What were LMAT's earnings last quarter?
LMAT's most recent reported quarter was Q2 2026. Net income was $17M with diluted EPS of $0.74. For a full breakdown of all quarters, see the quarterly earnings table on this page.